Botulinum toxin type B in upper-limb poststroke spasticity: A double-blind, placebo-controlled trial 11No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.
- 1 May 2004
- journal article
- Published by Elsevier in Archives of Physical Medicine and Rehabilitation
- Vol. 85 (5), 705-709
- https://doi.org/10.1016/j.apmr.2003.08.077
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Treatment with botulinum toxin type B for upper-limb spasticityArchives of Physical Medicine and Rehabilitation, 2003
- Inter- and intrarater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb poststroke spasticityArchives of Physical Medicine and Rehabilitation, 2002
- Intramuscular Injection of Botulinum Toxin for the Treatment of Wrist and Finger Spasticity after a StrokeNew England Journal of Medicine, 2002
- Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–resistant cervical dystoniaNeurology, 1999
- Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–responsive cervical dystoniaNeurology, 1999
- Adult Norms for the Nine Hole Peg Test of Finger DexterityThe Occupational Therapy Journal of Research, 1985